The National Evaluation System for health Technology (NEST) enhances the medical device postmarket surveillance system by better producing evidence for medical device assessment and regulatory decision-making. According to the FDA, NEST “leverag[es] real-world evidence and appl[ies] advanced analytics to data tailored to the unique data needs and innovation cycles of medical devices”. This evidence comes from many sources, including medical bill claims, electronic health records and clinical registries.
This system is governed by the NEST Coordinating Center (NESTcc), who will monitor the entire operation. This includes ensuring the compliance and proper standards of the surveillance system.
NEST makes it easier for both providers and patients to make improved decisions that align with proper treatment and allows them the freedom to be innovative and make information more accessible.
RegDesk is an A.I.-powered regulatory intelligence software that offers 24/7 access to the latest regulatory information for over 50 markets worldwide. Our platform eliminates the need for medical device companies to spend months gathering intelligence and preparing their registration applications. Through RegDesk’s centralized platform, clients can get access to product-specific registration requirements, expert answers to their most critical regulatory questions, and real-time alerts about global regulatory changes. To experience the power of RegDesk, contact us at email@example.com or visit www.regdesk.co.